Journal of the American Academy of Dermatology
Volume 58, Issue 6 , Pages 1031-1042, June 2008

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening

  • Alexa B. Kimball, MD, MPH

      Affiliations

    • Department of Dermatology at Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts
    • Corresponding Author InformationReprint requests: Alexa B. Kimball, MD, Massachusetts General and Brigham and Women's Hospitals, 50 Staniford St, #246, Boston, MA 02114.
  • ,
  • Dafna Gladman, MD

      Affiliations

    • Department of Dermatology, Toronto Western Research Institute, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Canada
  • ,
  • Joel M. Gelfand, MD, MSCE

      Affiliations

    • Department of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania
  • ,
  • Kenneth Gordon, MD

      Affiliations

    • Division of Dermatology, Evanston Northwestern Healthcare, Skokie, Illinois
  • ,
  • Elizabeth J. Horn, PhD, MBI

      Affiliations

    • Division of Dermatology, National Psoriasis Foundation, Portland, Oregon
  • ,
  • Neil J. Korman, MD, PhD

      Affiliations

    • Division of Dermatology, Murdough Family Center for Psoriasis, Case Western Reserve University/University Hospital of Cleveland, Cleveland, Ohio
  • ,
  • Gretchen Korver, MD, PhD

      Affiliations

    • Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah
  • ,
  • Gerald G. Krueger, MD

      Affiliations

    • Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah
  • ,
  • Bruce E. Strober, MD, PhD

      Affiliations

    • Ronald O. Perelman Department of Dermatology, New York University, New York, New York
  • ,
  • Mark G. Lebwohl, MD

      Affiliations

    • Department of Dermatology, Mount Sinai School of Medicine, New York, New York
  • ,
  • National Psoriasis Foundation

published online 29 February 2008.

There have been several articles and reports in recent months about comorbidities and risks that affect psoriasis patients in addition to their underlying disease. This piece reviews the current literature and begins to address what should be done with this new information by updating the clinician about what health screening tests, preventative exams, and referrals should be considered in this population.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the National Psoriasis Foundation and the National Institutes of Health grant K23AR051125-01, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Dr Gelfand).

 Disclosures: Dr Kimball is an investigator and consultant for Abbott, Centocor, and Amgen, and receives funding for a fellowship from Centocor. Dr Gladman is a consultant to Abbott, Amgen, Centocor, Schering-Plough, and Wyeth and received unrestricted research grant support from Abbott Canada, Amgen-Wyeth Canada, Schering Plough Canada, Pfizer Canada, and Wyeth Global. Dr Gelfand is an investigator for or receives grant support from Amgen, Abbott, and Centocor. He is a consultant for Amgen, Centocor, and Genentech and his practice provides phototherapies. Dr Gordon has received research support and honoraria from Abbott, Amgen, and Centocor. Dr Horn was an employee of the National Psoriasis Foundation. The National Psoriasis Foundation receives unrestricted funding from Abbott Immunology, Amgen and Wyeth, Astellas Pharma, Inc, Barrier Therapeuics, Beiersdorf, Centocor, Daavlin, Galderma Laboratories, Genentech, National Biologic Corporation, Neutrogena, Photomedex, Stiefel Laboratories, and Warner Chilcott. Dr Korman is an investigator for or receives grant support from Abbott Laboratories, Amgen, Astellas, Biogen Idec, Centocor, Genentech, Genmab, Novartis, Peplin, and Seattle Genetics. He is also a speaker or consultant for Abbott Laboratories, Amgen, Genentech, Genmab, Novartis, and Peplin, and his practice provides phototherapy services. Dr Korver has received some fellowship support from Amgen and Centocor. Dr Krueger is a consultant or advisory board member for Abbott, Almirall, Alza, Amgen, Astellas, Barrier Therapeutics, Boehringer Ingleheim, Bristol Myers Squibb, Centocor, Connetics, Genentech, Genzyme, L'Oreal, Magen Biosciencs, MedaCorp, Medicis, Novartis, Schering Plough, Warner Chilcot, and ZARS. He owns equities and stock options in/from ZARS. Dr Krueger has received lecture fees from Abbott, Amgen, Astellas, Boehringer Ingleheim, Centocor, Connetics, and Warner Chilcott, and partial stipend support for a clinical research fellowship from Abbott, Amgen, and Centocor. Dr Strober is a speaker, advisor, and/or investigator for Amgen-Wyeth, Abbott, Centocor, Astellas, and Genentech. Dr Lebwohl is an investigator for Abbott Laboratories, Amgen, Astellas, Centocor, Connetics, Galderma, Genentech, 3M, Novartis, and Warner Chilcott. He is also a consultant for Abbott, Amgen, Astellas, BristolMyersSquibb, Centocor, Connetics, Galderma, Genentech, 3M, Novartis, Pfizer, and Warner Chilcott and speaker for Abbott, Amgen, Astellas, Centocor, Chester Valley, Connetics, Galderma, Genentech, 3M, Novartis, PharmaDerm, and Warner Chilcott, and his practice provides phototherapy services.

PII: S0190-9622(08)00119-9

doi:10.1016/j.jaad.2008.01.006

Journal of the American Academy of Dermatology
Volume 58, Issue 6 , Pages 1031-1042, June 2008